130 related articles for article (PubMed ID: 34178164)
1. Augmenting Both Arms of a Randomized Controlled Trial Using External Data: An Application of the Propensity Score-Integrated Approaches.
Li H; Chen WC; Wang C; Lu N; Song C; Tiwari R; Xu Y; Yue LQ
Stat Biosci; 2022; 14(1):79-89. PubMed ID: 34178164
[TBL] [Abstract][Full Text] [Related]
2. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
[TBL] [Abstract][Full Text] [Related]
3. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.
Chen WC; Wang C; Li H; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):508-520. PubMed ID: 32370640
[TBL] [Abstract][Full Text] [Related]
4. Propensity score-based methods for causal inference and external data leveraging in regulatory settings: From basic ideas to implementation.
Li H; Yue LQ
Pharm Stat; 2023; 22(4):721-738. PubMed ID: 36794571
[TBL] [Abstract][Full Text] [Related]
5. Principled leveraging of external data in the evaluation of diagnostic devices via the propensity score-integrated composite likelihood approach.
Song C; Li H; Chen WC; Lu N; Tiwari R; Wang C; Xu Y; Yue LQ
Pharm Stat; 2023; 22(3):547-569. PubMed ID: 36871949
[TBL] [Abstract][Full Text] [Related]
6. A propensity score-integrated approach for leveraging external data in a randomized controlled trial with time-to-event endpoints.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
Pharm Stat; 2024 Mar; ():. PubMed ID: 38442919
[TBL] [Abstract][Full Text] [Related]
7. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
[TBL] [Abstract][Full Text] [Related]
8. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
9. An Improved Matching Practice for Augmenting a Randomized Clinical Trial with External Control.
Li J; Du Y; Liu H; Yi Y
Ther Innov Regul Sci; 2023 May; 57(3):611-618. PubMed ID: 36809484
[TBL] [Abstract][Full Text] [Related]
10. Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials.
Wei W; Zhang Y; Roychoudhury S;
Stat Med; 2024 Jun; ():. PubMed ID: 38924575
[TBL] [Abstract][Full Text] [Related]
11. Semi-supervised mixture multi-source exchangeability model for leveraging real-world data in clinical trials.
Haine LMF; Murry TA; Nahra R; Touloumi G; Fernández-Cruz E; Petoumenos K; Koopmeiners JS
Biostatistics; 2023 Sep; ():. PubMed ID: 37697901
[TBL] [Abstract][Full Text] [Related]
12. A Two-Step Bayesian Approach for Propensity Score Analysis: Simulations and Case Study.
Kaplan D; Chen J
Psychometrika; 2012 Jul; 77(3):581-609. PubMed ID: 27519782
[TBL] [Abstract][Full Text] [Related]
13. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
Baron E; Zhu J; Tang RS; Chen MH
J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
Tan WK; Segal BD; Curtis MD; Baxi SS; Capra WB; Garrett-Mayer E; Hobbs BP; Hong DS; Hubbard RA; Zhu J; Sarkar S; Samant M
Contemp Clin Trials Commun; 2022 Dec; 30():101000. PubMed ID: 36186544
[TBL] [Abstract][Full Text] [Related]
16. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
17. Rectus femoris transfer in children with cerebral palsy: comparing a propensity score-matched observational study to a randomized controlled trial.
Schwartz MH; Ries AJ
Dev Med Child Neurol; 2021 Feb; 63(2):196-203. PubMed ID: 33084049
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
[TBL] [Abstract][Full Text] [Related]
20. Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective.
Arjas E; Gasbarra D
BMC Med Res Methodol; 2022 Feb; 22(1):50. PubMed ID: 35184731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
